Nathalie Adda

Insider Reports History

Entity
Individual
Location
C/O Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown, MA
Signature
/s/ Nathaniel S. Gardiner as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathalie Adda:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ENANTA PHARMACEUTICALS INC Sr. VP & Chief Medical Officer Common Stock 35K $319K $9.12 Apr 4, 2022 Direct
ENANTA PHARMACEUTICALS INC Sr. VP & Chief Medical Officer Stock Option (Right to Buy) 13.1K Apr 4, 2022 Direct

Insider Reports Filed by Nathalie Adda

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ENTA ENANTA PHARMACEUTICALS INC Apr 1, 2022 18 -$2.58M 4 Apr 5, 2022 Sr. VP & Chief Medical Officer
ENTA ENANTA PHARMACEUTICALS INC Mar 1, 2022 7 -$984K 4 Mar 3, 2022 Sr. VP & Chief Medical Officer
ENTA ENANTA PHARMACEUTICALS INC Feb 14, 2022 3 -$59.6K 4 Feb 15, 2022 Sr. VP & Chief Medical Officer
ENTA ENANTA PHARMACEUTICALS INC Jan 11, 2022 5 -$379K 4 Jan 13, 2022 Sr. VP & Chief Medical Officer
ENTA ENANTA PHARMACEUTICALS INC Dec 1, 2021 12 -$630K 4 Dec 3, 2021 Sr. VP & Chief Medical Officer
ENTA ENANTA PHARMACEUTICALS INC Nov 19, 2021 2 $0 4 Nov 23, 2021 Sr. VP & Chief Medical Officer
ENTA ENANTA PHARMACEUTICALS INC Nov 1, 2021 5 -$347K 4 Nov 2, 2021 Sr. VP & Chief Medical Officer
ENTA ENANTA PHARMACEUTICALS INC Oct 8, 2021 6 -$467K 4 Oct 13, 2021 Sr. VP & Chief Medical Officer